A DNA repair disorder caused by de novo monoallelic DDB1 variants is associated with a neurodevelopmental syndrome
Susan M. White(The University of Melbourne), Kristin D. Kernohan(University of Ottawa), Alison S. May(Columbia University Irving Medical Center), Katrin Õunap(Tartu University Hospital), Marjan M. Nezarati(North York General Hospital), Koen L.I. van Gassen(University Medical Center Utrecht), Simon Sadedin(Murdoch Children's Research Institute), Christoffer Nellåker, John Christodoulou(The University of Melbourne), Tiong Yang Tan(Royal Children's Hospital), Wendy E. Smith(Maine Medical Center), Kym M. Boycott(University of Ottawa), Aren E. Marshall(University of Ottawa), Taila Hartley(University of Ottawa), Dagmar Wieczorek(Essen University Hospital), Rami Abou Jamra(Leipzig University), Margarete Koch‐Hogrebe(Klinikum Vest), Elizabeth Bhoj(Children's Hospital of Philadelphia), Dong Li(Children's Hospital of Philadelphia), Sara Ellingwood, Augusta M.A. Lachmeijer(University Medical Center Utrecht), Jaime Barea, Arran McBride(University of Ottawa), Paul J. Lockhart(The University of Melbourne), Michelle Ernst(A&G Pharmaceutical (United States)), Sander Pajusalu(MACOM (United States))
Cited by 16
Related Papers
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
|Genetics in Medicine|2014|718
Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases
|npj Genomic Medicine|2018|637
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596